Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
Brenda E Porter, Catherine Jacobso. Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy. Epilepsy & behavior : E&B. vol 29. issue 3. 2014-07-03. PMID:24237632. |
nineteen responses met the following inclusion criteria for the study: a diagnosis of epilepsy and current use of cannabidiol-enriched cannabis. |
2014-07-03 |
2023-08-12 |
Not clear |
Brenda E Porter, Catherine Jacobso. Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy. Epilepsy & behavior : E&B. vol 29. issue 3. 2014-07-03. PMID:24237632. |
our survey shows that parents are using cannabidiol-enriched cannabis as a treatment for their children with treatment-resistant epilepsy. |
2014-07-03 |
2023-08-12 |
Not clear |
Brenda E Porter, Catherine Jacobso. Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy. Epilepsy & behavior : E&B. vol 29. issue 3. 2014-07-03. PMID:24237632. |
because of the increasing number of states that allow access to medical cannabis, its use will likely be a growing concern for the epilepsy community. |
2014-07-03 |
2023-08-12 |
Not clear |
Hilary A Enuh, Julia Chin, Jay Nfonoyi. Cannabinoid hyperemesis syndrome with extreme hydrophilia. International journal of general medicine. vol 6. 2013-08-28. PMID:23983485. |
he had a history of epilepsy and addiction to marijuana, which he took on the day of admission. |
2013-08-28 |
2023-08-12 |
Not clear |
Mackenzie E Hofmann, Charles J Frazie. Marijuana, endocannabinoids, and epilepsy: potential and challenges for improved therapeutic intervention. Experimental neurology. vol 244. 2013-08-02. PMID:22178327. |
marijuana, endocannabinoids, and epilepsy: potential and challenges for improved therapeutic intervention. |
2013-08-02 |
2023-08-12 |
human |
Manu Hegde, Carlos Santos-Sanchez, Christopher P Hess, Arif A Kabir, Paul A Garci. Seizure exacerbation in two patients with focal epilepsy following marijuana cessation. Epilepsy & behavior : E&B. vol 25. issue 4. 2013-05-17. PMID:23159379. |
seizure exacerbation in two patients with focal epilepsy following marijuana cessation. |
2013-05-17 |
2023-08-12 |
Not clear |
Manu Hegde, Carlos Santos-Sanchez, Christopher P Hess, Arif A Kabir, Paul A Garci. Seizure exacerbation in two patients with focal epilepsy following marijuana cessation. Epilepsy & behavior : E&B. vol 25. issue 4. 2013-05-17. PMID:23159379. |
both stopped marijuana upon admission to our epilepsy monitoring unit (emu) and developed a dramatic increase in seizure frequency documented by video-eeg telemetry. |
2013-05-17 |
2023-08-12 |
Not clear |
Nicholas A Jones, Sarah E Glyn, Satoshi Akiyama, Thomas D M Hill, Andrew J Hill, Samantha E Weston, Matthew D A Burnett, Yuki Yamasaki, Gary J Stephens, Benjamin J Whalley, Claire M William. Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures. Seizure. vol 21. issue 5. 2012-08-30. PMID:22520455. |
cannabis sativa has been associated with contradictory effects upon seizure states despite its medicinal use by numerous people with epilepsy. |
2012-08-30 |
2023-08-12 |
human |
Nicholas A Jones, Sarah E Glyn, Satoshi Akiyama, Thomas D M Hill, Andrew J Hill, Samantha E Weston, Matthew D A Burnett, Yuki Yamasaki, Gary J Stephens, Benjamin J Whalley, Claire M William. Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures. Seizure. vol 21. issue 5. 2012-08-30. PMID:22520455. |
we have recently shown that the phytocannabinoid cannabidiol (cbd) reduces seizure severity and lethality in the well-established in vivo model of pentylenetetrazole-induced generalised seizures, suggesting that earlier, small-scale clinical trials examining cbd effects in people with epilepsy warrant renewed attention. |
2012-08-30 |
2023-08-12 |
human |
Angelo A Izzo, Francesca Borrelli, Raffaele Capasso, Vincenzo Di Marzo, Raphael Mechoula. Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends in pharmacological sciences. vol 30. issue 10. 2009-12-11. PMID:19729208. |
special emphasis is given to cannabidiol, the possible applications of which have recently emerged in inflammation, diabetes, cancer, affective and neurodegenerative diseases, and to delta(9)-tetrahydrocannabivarin, a novel cb(1) antagonist which exerts potentially useful actions in the treatment of epilepsy and obesity. |
2009-12-11 |
2023-08-12 |
Not clear |
Joseph I Sirve. Alternative therapies for seizures: promises and dangers. Seminars in neurology. vol 27. issue 4. 2007-11-28. PMID:17701869. |
evidence-based data regarding cam for epilepsy are presented as well as potential safety concerns regarding ephedra and cannabis use. |
2007-11-28 |
2023-08-12 |
Not clear |
Katherine Mortati, Barbara Dworetzky, Orrin Devinsk. Marijuana: an effective antiepileptic treatment in partial epilepsy? A case report and review of the literature. Reviews in neurological diseases. vol 4. issue 2. 2007-11-06. PMID:17609644. |
marijuana: an effective antiepileptic treatment in partial epilepsy? |
2007-11-06 |
2023-08-12 |
Not clear |
Katherine Mortati, Barbara Dworetzky, Orrin Devinsk. Marijuana: an effective antiepileptic treatment in partial epilepsy? A case report and review of the literature. Reviews in neurological diseases. vol 4. issue 2. 2007-11-06. PMID:17609644. |
although more data are needed, animal studies and clinical experience suggest that marijuana or its active constituents may have a place in the treatment of partial epilepsy. |
2007-11-06 |
2023-08-12 |
Not clear |
Katherine Mortati, Barbara Dworetzky, Orrin Devinsk. Marijuana: an effective antiepileptic treatment in partial epilepsy? A case report and review of the literature. Reviews in neurological diseases. vol 4. issue 2. 2007-11-06. PMID:17609644. |
here we present the case of a 45-year-old man with cerebral palsy and epilepsy who showed marked improvement with the use of marijuana. |
2007-11-06 |
2023-08-12 |
Not clear |
Mariachiara Cortesi, Paolo Fusar-Pol. Potential therapeutical effects of cannabidiol in children with pharmacoresistant epilepsy. Medical hypotheses. vol 68. issue 4. 2007-07-18. PMID:17112679. |
potential therapeutical effects of cannabidiol in children with pharmacoresistant epilepsy. |
2007-07-18 |
2023-08-12 |
Not clear |
Joseph I Sirven, Anne T Ber. Marijuana as a treatment for epilepsy and multiple sclerosis? A "grass roots" movement. Neurology. vol 62. issue 11. 2004-12-20. PMID:15184589. |
marijuana as a treatment for epilepsy and multiple sclerosis? |
2004-12-20 |
2023-08-12 |
Not clear |
D W Gross, J Hamm, N L Ashworth, D Quigle. Marijuana use and epilepsy: prevalence in patients of a tertiary care epilepsy center. Neurology. vol 62. issue 11. 2004-12-20. PMID:15184622. |
twenty-four percent of all subjects believed marijuana was an effective therapy for epilepsy. |
2004-12-20 |
2023-08-12 |
human |
D W Gross, J Hamm, N L Ashworth, D Quigle. Marijuana use and epilepsy: prevalence in patients of a tertiary care epilepsy center. Neurology. vol 62. issue 11. 2004-12-20. PMID:15184622. |
despite limited evidence of efficacy, many patients with epilepsy believe marijuana is an effective therapy for epilepsy and are actively using it. |
2004-12-20 |
2023-08-12 |
human |
Beat Lut. On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures. Biochemical pharmacology. vol 68. issue 9. 2004-11-23. PMID:15450934. |
extracts of cannabis sativa have a long history in the treatment of various neurological diseases, including epilepsy. |
2004-11-23 |
2023-08-12 |
mouse |
J D Wilkinson, B J Whalley, D Baker, G Pryce, A Constanti, S Gibbons, E M Williamso. Medicinal cannabis: is delta9-tetrahydrocannabinol necessary for all its effects? The Journal of pharmacy and pharmacology. vol 55. issue 12. 2004-03-30. PMID:14738597. |
we have compared the effect of a standardized cannabis extract (sce) with pure delta9thc, at matched concentrations of delta9thc, and also with a delta9thc-free extract (delta9thc-free sce), using two cannabinoid-sensitive models, a mouse model of multiple sclerosis (ms), and an in-vitro rat brain slice model of epilepsy. |
2004-03-30 |
2023-08-12 |
mouse |